推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 科思創(chuàng)10月29日宣布，作為其全球MDI投資計(jì)劃的一部分，計(jì)劃在比利時(shí)安特衛(wèi)普生產(chǎn)基地投資約3億歐元，用于新建苯胺生產(chǎn)裝置。
科思創(chuàng)表示，新裝置預(yù)計(jì)將于2022年啟動(dòng)。安特衛(wèi)普(Antwerp)工廠作為科思創(chuàng)的歐洲苯胺中心，得益于港口中心具有吸引力的基礎(chǔ)設(shè)施和物流條件，且能夠獲得生產(chǎn)苯胺所需的原材料。苯胺是許多化學(xué)產(chǎn)品(包括MDI)的重要原料。
科思創(chuàng)表示，這項(xiàng)投資增加苯胺產(chǎn)量，將確保歐洲MDI生產(chǎn)網(wǎng)絡(luò)的可持續(xù)和高效供應(yīng)，其中包括西班牙塔拉戈納工廠的產(chǎn)能增加。此外，該投資項(xiàng)目最終將提供額外的工作崗位。
科思創(chuàng)預(yù)計(jì)。長(zhǎng)期來看，全球MDI市場(chǎng)預(yù)計(jì)將以每年5%左右的速度增長(zhǎng)，增速將超過全球國(guó)內(nèi)生產(chǎn)總值(GDP)約2個(gè)百分點(diǎn)。隨著全球MDI投資計(jì)劃的實(shí)施，科思創(chuàng)目前正在加快其投資活動(dòng)，以利用預(yù)期強(qiáng)勁的MDI市場(chǎng)增長(zhǎng)。
